DEF: FMC Corp. Seeks Shareholder Approval for Governance, Compensation Reforms

FMC Corporation's latest proxy statement outlines proposals for its 2026 Annual Meeting, including director elections, executive compensation advisory vote, and significant corporate governance amendments aimed at enhancing shareholder rights.

Summary

• The 2026 Annual Meeting of Stockholders will be held virtually on Tuesday, April 28, 2026, at 2:00 p.m. EDT.
• Ten directors are nominated for election, each for a one-year term, including new appointee Michael F. Barry. The Board size will be reduced from 13 to 10 directors.
• Shareholders will vote on the ratification of KPMG LLP as the independent registered public accounting firm for 2026.
• An advisory (non-binding) vote on executive compensation will be held. The company received 50.56% support for its Say-on-Pay resolution in 2025, prompting engagement efforts and program modifications.
• Proposals 4 and 5 seek to eliminate supermajority voting provisions in the Certificate of Incorporation, which previously failed to meet the 80% approval threshold in 2025 despite over 73% support.
• Proposal 6 aims to amend the Certificate of Incorporation and By-Laws to grant stockholders owning 25% or more of outstanding common stock the right to call a special meeting, following a 2025 proposal for a 10% threshold that received 63.2% support.
• Proposal 7 involves approving certain miscellaneous amendments to modernize the Certificate of Incorporation.
• Proposal 8 requests approval for the FMC Corporation 2026 Incentive Stock Plan, which will replace the 2023 plan and includes a reserve of 5,250,000 new shares, plus recycled shares from prior plans.
• Executive compensation changes include basing the annual incentive plan on a single performance metric of EBITDA starting in 2025 and, for 2026, removing the banking feature for rTSR PSUs, subjecting them to a single three-year performance period.
• FMC reported a revenue decrease of 18% to $3.47 billion in 2025, with a GAAP net loss of $2.24 billion, primarily due to a non-cash goodwill impairment and charges related to the India commercial business divestment.
• Adjusted EBITDA declined 7% and Adjusted Earnings declined 15% in 2025.
• The CEO pay ratio for fiscal 2025 was 191 to 1, with the CEO's total compensation at $12,038,391 and the median employee's at $62,961.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing with cautious optimism. While the company is proactively addressing corporate governance and executive compensation concerns, the significant financial underperformance in 2025 and the negative impact on shareholder returns are substantial negatives. The strategic initiatives and improved governance are positive long-term signals, but the immediate financial results are concerning.

Positives

• Proposals to eliminate supermajority voting provisions (Proposals 4 & 5) and grant stockholders the right to call a special meeting at a 25% ownership threshold (Proposal 6) enhance corporate governance and shareholder rights.
• The 2026 Incentive Stock Plan includes strong governance features such as restrictions against liberal share recycling, director compensation limits, robust clawback provisions, prohibition of repricing without stockholder approval, and no single-trigger vesting on change in control.
• Executive compensation program modifications, including the shift to a single EBITDA metric for annual incentives and removal of the rTSR PSU banking feature, aim to increase simplicity, transparency, and alignment with long-term shareholder interests.
• The company's strategic ambitions focus on innovation, efficient operations, expanding biologicals business, and leadership in sustainability, safety, and talent.
• The company is actively addressing shareholder feedback regarding executive compensation, demonstrating responsiveness to governance concerns.

Negatives

• Low shareholder support (50.56%) for the Say-on-Pay resolution at the 2025 annual meeting indicates significant shareholder dissatisfaction with executive compensation.
• Previous management proposals to eliminate supermajority voting failed to meet the 80% approval threshold, suggesting ongoing resistance or difficulty in achieving significant governance reforms.
• Significant financial decline in 2025: 18% decrease in revenue to $3.47 billion, a GAAP net loss of $2.24 billion (down $2.58 billion), 7% decline in Adjusted EBITDA, and 15% decline in Adjusted Earnings.
• The net loss was primarily driven by a non-cash goodwill impairment and charges related to the India commercial business divestment, indicating asset value write-downs and operational challenges.
• The three-year cumulative total stockholder return was negatively affected by a substantial share price reduction starting July 2023, reflecting poor market performance.
• No PSU award payouts under the 2023 performance grant (matured December 31, 2025) for NEOs, and 0% rTSR achievement for 2024 and 2025 grants, directly reflecting poor stock performance.
• The Chief Financial Officer (Andrew Sandifer) does not meet the company's share ownership requirement as of December 31, 2025, due to stock price decline.

Risks

• Ongoing commercial challenges in India led to the decision to divest the commercial business there.
• High market competition, ample manufacturing capacity, and challenging grower margins for many crops negatively impacted results.
• Continuing headwinds in the agricultural industry could further pressure financial performance.
• Inability to grant equity-based compensation if the 2026 Incentive Stock Plan is not approved, potentially impacting the ability to attract and retain talent.
• The 12-month delay in the effectiveness of the Section 203 Opt-Out and Mirror Provision means Section 203 will continue to apply for that period, requiring a 66 2/3% disinterested stockholder vote for certain business combinations.
• Special meetings, if called by shareholders, can result in substantial expenses and divert management attention.

Future Outlook

The company anticipates continued pressure on its share price due to industry destocking, high market competition, and challenging grower margins. It plans to complete the divestment of its India commercial business in 2026 and is focused on strategic initiatives to drive growth, innovation, and sustainability. The executive compensation program for 2026 has been modified to better align with long-term shareholder interests.

Management Comments

• "We welcome this opportunity to have a dialogue with our stockholders and look forward to your comments and questions." Pierre Brondeau, Chairman, CEO and President.
• "During the meeting, I will report on the Company’s earnings, results and other achievements during 2025 and on our outlook for 2026." Pierre Brondeau.
• "The Board believes that our executive compensation program, as modified based on feedback from our stockholders, properly incentivizes our executives to drive stockholder value, while appropriately managing risk, and aligns with our pay for performance philosophy."
• "The recent decline in our stock price performance in fiscal 2025 demonstrates this alignment, as shown in the actual amounts of pay realized by our executives."
• "The Board and Compensation Committee are continually focused on efforts to drive value for our stockholders, and believe that our executive compensation programs are appropriately designed to achieve that goal."
• "In charting the next 10 years at FMC, we are building on the strengths that have driven our success: strong innovation with a deep pipeline of new products and technologies; a resilient, efficient operations and supply chain model; strong market access; an expanding biologicals business; and being a leader in sustainability, safety, and talent."

Industry Context

StockSavvy.ai notes that FMC Corporation's challenges in 2025, including industry destocking, intense market competition, and difficult grower margins, reflect broader headwinds impacting the agricultural chemicals sector. The strategic focus on innovation, biologicals, and sustainability aligns with industry trends towards more environmentally conscious and technologically advanced farming solutions, which are critical for long-term resilience in a cyclical market. The divestment of the India commercial business indicates a strategic realignment to focus on core strengths and patented technologies in challenging regional markets.

Comparison to Industry Standards

• The proposal to allow stockholders to call a special meeting at a 25% ownership threshold is benchmarked against S&P 500 Index companies and the company's compensation peer group, where 25% is noted as the most common ownership threshold among those that allow such a right.
• The executive compensation program's shift to a single EBITDA metric for annual incentives and the removal of the rTSR PSU banking feature for 2026 grants are presented as responses to shareholder feedback and efforts to align with market-standard practices and pay-for-performance philosophies.
• The CEO pay ratio of 191 to 1 for 2025 is provided, with a note that comparability to other companies may vary due to different methodologies and compensation practices.

Management Changes

Corporate Governance

Related Party Transactions

• No related party transactions required to be approved or ratified by the Audit Committee or disclosed pursuant to SEC rules since January 1, 2025.
• The Board determined that purchases and sales with other companies on which a director served were de minimis (less than 0.3% of company revenues) and arose in the ordinary course of business on the same terms as other customers/suppliers, not affecting director independence.
• Mr. Davidson's consulting fee for serving on the Independent Audit Quality Committee of Ernst & Young, LLP was determined not to impair his independence, as he is not a partner/member/officer of Ernst & Young, LLP and his role is not linked to FMC's contractual relationship with them.

Stakeholder Impact

• Shareholders: Enhanced rights through proposals to eliminate supermajority voting and grant the right to call special meetings. Potential for improved long-term value creation through a more aligned and transparent executive compensation program. Negative impact on share price and total shareholder return in 2025.
• Employees: The 2026 Incentive Stock Plan aims to recruit and retain highly qualified employees by providing incentives for productivity and opportunities to share in company growth. Executive compensation changes are designed to motivate performance.
• Management: Executive compensation is tied to company performance, with significant portions at-risk. Changes to the incentive plan aim to simplify metrics and align with business results.
• Customers/Suppliers: The divestment of the India commercial business includes a supply agreement with the eventual buyer for FMC's patented portfolio, indicating continued engagement in the market through a different model.
• Regulatory Authorities: The company is committed to compliance with SEC and NYSE rules, including those related to auditor independence, executive compensation disclosure, and corporate governance.

Next Steps

• Hold the 2026 Annual Meeting of Stockholders on April 28, 2026, to vote on the proposals.
• If approved, the Board intends to amend the Certificate of Incorporation and By-Laws to eliminate supermajority voting provisions, provide stockholders the right to call special meetings, and implement miscellaneous changes.
• If approved, the 2026 Incentive Stock Plan will replace the 2023 plan, and no new awards will be granted under the 2023 plan.
• The company plans to complete the divestment of its India commercial business in 2026.
• The Compensation Committee will continue to consider stockholder advisory votes and input on executive compensation when making future decisions.
• The next advisory vote on executive compensation will be held at the 2027 Annual Meeting.
• The Board will review director compensation on an annual basis, commencing with fiscal year 2027.
• Eduardo E. Cordeiro is expected to serve as Lead Director for a two-year term commencing after the conclusion of the 2026 Annual Meeting.

Key Dates

Recommendation

The filing presents a mixed bag. While FMC Corporation is proactively addressing corporate governance concerns and making positive changes to its executive compensation structure in response to shareholder feedback, the significant financial underperformance in 2025, including a substantial net loss and declines in revenue and EBITDA, is a major concern. The negative impact on total shareholder return and the failure of the CFO to meet share ownership guidelines due to stock price decline highlight operational and market challenges. The proposed governance changes, if approved, could improve long-term shareholder value by enhancing accountability and flexibility. However, the immediate financial results and ongoing industry headwinds suggest a "hold" recommendation, as the company navigates a challenging period while implementing strategic and governance reforms. Investors should monitor the execution of the India divestment and the impact of the new compensation and governance structures on future performance.

Keywords

FMC Corporation, Proxy Statement, Corporate Governance, Executive Compensation, Shareholder Rights, Supermajority Voting, Incentive Stock Plan, Director Election, Financial Performance, Agricultural Sciences, EBITDA, Total Shareholder Return (TSR), Goodwill Impairment, India Divestment, Risk Management